Health BSF Enterprise drops 10.56% as Indigo Capital debt conversion triggers dilution By Ian Lyall 25/08
Health Oxford Nanopore target price hiked to 196p by Panmure Liberum on strategic pivot By Ian Lyall 24/08
Health EDX Medical jumps 33% after £2.7m 'premium' fundraise to expand health screening By Ian Lyall 24/08
Mining SMALL-CAP MOVERS: The numbers that prove AIM is being bought out from under us By Ian Lyall 21/08
Health Cancer vaccine breakthrough at Moderna raises hopes for Scancell's melanoma programme By Ian Lyall 20/08
Health GSK shares kept at neutral by Citi as unproven phase III pipeline curbs long-term growth By Ian Lyall 20/08
Health Shield Therapeutics jumps 11% as losses narrow and profitability target held By Ian Lyall 20/08
Health Nuformix gains 19% in London trade on positive NXP002 study ahead of ERS Congress By Ian Lyall 19/08
Health Deutsche Bank trims Oxford BioMedica target by 26% after weak trading update By Proactive 18/08
Retail & consumer Diageo appoints former P&G Beauty chief R. Alexandra Keith to board By Ephrem Joseph 18/08